ATE129284T1 - Attenuiertes hundeparvovirus (cpv), cpv enthaltender impfstoff und verfahren zur verhütung von infektionen durch cpv bei hunden. - Google Patents

Attenuiertes hundeparvovirus (cpv), cpv enthaltender impfstoff und verfahren zur verhütung von infektionen durch cpv bei hunden.

Info

Publication number
ATE129284T1
ATE129284T1 AT90911906T AT90911906T ATE129284T1 AT E129284 T1 ATE129284 T1 AT E129284T1 AT 90911906 T AT90911906 T AT 90911906T AT 90911906 T AT90911906 T AT 90911906T AT E129284 T1 ATE129284 T1 AT E129284T1
Authority
AT
Austria
Prior art keywords
cpv
dogs
canine parvovirus
infections caused
vaccine containing
Prior art date
Application number
AT90911906T
Other languages
English (en)
Inventor
David Ross Mcgavin
Lynette Lavidis
Original Assignee
Webster Arthur Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Webster Arthur Pty Ltd filed Critical Webster Arthur Pty Ltd
Application granted granted Critical
Publication of ATE129284T1 publication Critical patent/ATE129284T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14361—Methods of inactivation or attenuation
    • C12N2750/14364—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT90911906T 1989-08-08 1990-08-08 Attenuiertes hundeparvovirus (cpv), cpv enthaltender impfstoff und verfahren zur verhütung von infektionen durch cpv bei hunden. ATE129284T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPJ567089 1989-08-08

Publications (1)

Publication Number Publication Date
ATE129284T1 true ATE129284T1 (de) 1995-11-15

Family

ID=3774102

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90911906T ATE129284T1 (de) 1989-08-08 1990-08-08 Attenuiertes hundeparvovirus (cpv), cpv enthaltender impfstoff und verfahren zur verhütung von infektionen durch cpv bei hunden.

Country Status (6)

Country Link
EP (1) EP0485463B1 (de)
AT (1) ATE129284T1 (de)
DE (1) DE69023140T2 (de)
DK (1) DK0485463T3 (de)
NZ (1) NZ234815A (de)
WO (1) WO1991002054A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2223029A1 (en) 1997-02-12 1998-08-12 Akzo Nobel Nv Canine parvovirus dna vaccines
EP0863151A1 (de) * 1997-02-12 1998-09-09 Akzo Nobel N.V. Hundeparvovirus DNA Impfstoffe
US20110091490A1 (en) * 2000-06-30 2011-04-21 Nippon Zenyaku Kogyo Co., Ltd. Novel vaccine for dog
US7682619B2 (en) 2006-04-06 2010-03-23 Cornell Research Foundation, Inc. Canine influenza virus
CN113073083B (zh) * 2020-01-03 2022-09-06 普莱柯生物工程股份有限公司 犬细小病毒弱毒株、及其制备的疫苗组合物和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4193991A (en) * 1978-12-20 1980-03-18 Cornell Research Foundation, Inc. Canine parvovirus vaccine
AU539224B2 (en) * 1980-04-18 1984-09-13 Cornell Research Foundation Inc. Modified living canine parvovirus vaccine
EP0117767A1 (de) * 1983-01-07 1984-09-05 Mgi Pharma, Inc. Herstellung von Untereinheiten von Parvovirus-Vakzinen
IL70704A0 (en) * 1983-01-19 1984-04-30 Amgen Methods and materials for development of parvovirus vaccines
GB8502399D0 (en) * 1985-01-31 1985-03-06 Akzo Nv Canine parvovirus vaccines

Also Published As

Publication number Publication date
NZ234815A (en) 1992-12-23
EP0485463A4 (en) 1993-02-17
DK0485463T3 (da) 1995-11-27
DE69023140D1 (de) 1995-11-23
WO1991002054A1 (en) 1991-02-21
EP0485463A1 (de) 1992-05-20
DE69023140T2 (de) 1996-03-21
EP0485463B1 (de) 1995-10-18

Similar Documents

Publication Publication Date Title
DE69919754D1 (de) Verwendung von aufgereinigtem invaplex als impfstoff für gram-negativebakterien
ATE430200T1 (de) Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
PL304419A1 (en) Urease based vaccine against heliobacter infections
AU4691589A (en) Feline infectious peritonitis virus diagnostic tools
DE69936977D1 (de) Durch polynukleinsäuren vom reproduktiven und respiratorischen syndromvirus des schweines kodierte proteine
ATE244578T1 (de) Behandlung eines durch helicobakter verursachten gastroduodenalen krankheit
ATE91902T1 (de) Hundecoronavirus-impfstoff.
DK0465204T3 (da) Vaccine mod Lyme sygdom
DK0425082T3 (da) Vacciner
ATE129284T1 (de) Attenuiertes hundeparvovirus (cpv), cpv enthaltender impfstoff und verfahren zur verhütung von infektionen durch cpv bei hunden.
DK1666057T3 (da) Fremgangsmåde til fremstilling af en acellulær vaccine indeholdende Bordetella pertussis antigener
DE69527986D1 (de) Antigene arznei zur behandlung oder vorbeugung
DK311485D0 (da) Fremgangsmaade til fremstilling af ikke-toksisk lt-b-underenhed i e. coli-enterotoksin
IT8121312A0 (it) Vaccino vivente modificato per proteggere i cani contro infezioni da parvovirus canino, metodo diproduzione e uso di detto vaccino.
DE10399019I1 (de) Gefluegelkrankheit verursachende neue Bakterie unddaraus stammender Impfstoff
ATE420951T1 (de) Schützende epitope von adenylate-zyklase- hämolysin(ac-hly) und ihre verwendung zur behandlung oder verhütung von bordetella- infektionen
DE68921063D1 (de) Verfahren zur Herstellung von menschlichem Serumalbumin durch Gärung eines genetisch veränderten Mikroorganismus in Gegenwart eines Polyalkylens.
DK540688D0 (da) Vaccine til beskyttelse af katte mod katteinfektioes peritonitis
DK0623170T3 (da) Vacciner baseret på streptokinase
ATE39055T1 (de) Verfahren zur immunisierung von schweinen gegen die aujeszky-krankheit.
RU94014584A (ru) Листериозная рибосомальная вакцина
EP0178928A3 (de) Impfstoffe